Adagene Inc.Adagene Inc.Adagene Inc.

Adagene Inc.

No trades
No trades

Compare with Adagene Inc.


Market capitalization
‪151.63 M‬USD
−0.37USD
‪−17.66 M‬USD
‪7.69 M‬USD
‪42.17 M‬
Beta (1Y)
0.35
Next report date
Report period
EPS estimate
Revenue estimate

Details


CEO
Pei Zhi Luo
Headquarters
Suzhou
Founded
2011
IPO date
Feb 9, 2021
ISIN
US0053291078
CUSIP
005329107
FIGI
BBG00YZ6BYJ6
Identifiers
ISIN US0053291078
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.